Terms: = Lung cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Prognosis
27 results:
1. Incidence, prognostic factors, and a nomogram of cervical cancer with lung metastasis: A SEER-based study.
Shan Y; Ding Z; Chen A; Cui Z
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102757. PubMed ID: 38403266
[TBL] [Abstract] [Full Text] [Related]
2. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic impact of lung recurrence in patients with biliary tract cancer.
Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
[TBL] [Abstract] [Full Text] [Related]
4. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Pyo JS; Kim NY; Min KW; Kang DW
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
[No Abstract] [Full Text] [Related]
5. Microbiomes Detected by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing among HIV-Infected and Uninfected Patients with Pulmonary Infection.
Tan Y; Chen Z; Zeng Z; Wu S; Liu J; Zou S; Wang M; Liang K
Microbiol Spectr; 2023 Aug; 11(4):e0000523. PubMed ID: 37436163
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical features and related factors of invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease].
Zhang XH; Zhou C; Luo YM; Ge HQ; Liu HG; Wei HL; Zhang JC; Pan PH; Li XH; Zhou H; Cheng LN; Yi MQ; Zhang JR; Adila A; Peng LG; Liu Y; Pu JQ; Liu L; Feng HP; Zhou HX; Yi Q
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1692-1699. PubMed ID: 37302977
[No Abstract] [Full Text] [Related]
7. Newly diagnosed non-small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis.
Zhu M; Yi J; Su Y; Zhang Y; Gao Y; Xu X; Zhang S; Zhang Y; Huang K
Thorac Cancer; 2023 Jul; 14(19):1874-1882. PubMed ID: 37232276
[TBL] [Abstract] [Full Text] [Related]
8. [Development and validation of prognostic nomogram for malignant pleural mesothelioma].
Xie XJ; Chen JY; Jiang J; Duan H; Wu Y; Zhang XW; Yang SJ; Zhao W; Shen SS; Wu L; He B; Ding YY; Luo H; Liu SY; Han D
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):415-423. PubMed ID: 37188627
[No Abstract] [Full Text] [Related]
9. Segmentectomy versus lobectomy for small-sized pure solid non-small cell lung cancer.
Li Z; Xu W; Pan X; Wu W; Chen L
Thorac Cancer; 2023 Apr; 14(11):1021-1028. PubMed ID: 36882365
[TBL] [Abstract] [Full Text] [Related]
10. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
[TBL] [Abstract] [Full Text] [Related]
11. Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
Wen Q; Ge J; Lei Y; Zhang Y; Kong X; Wang W; Hou H; Wang Z; Qian S; Ding M; Dong M; Zhu L; Zhang M; Zhang X; Chen Q
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3989-4003. PubMed ID: 36030432
[TBL] [Abstract] [Full Text] [Related]
12. lung cancer-Specific Mortality Risk and Public Health Insurance: A Prospective Cohort Study in Chongqing, Southwest China.
Wang Y; Lei H; Li X; Zhou W; Wang G; Sun A; Wang Y; Wu Y; Peng B
Front Public Health; 2022; 10():842844. PubMed ID: 35570974
[TBL] [Abstract] [Full Text] [Related]
13. Associations of systemic inflammation markers with identification of pulmonary nodule and incident lung cancer in Chinese population.
Tian T; Lu J; Zhao W; Wang Z; Xu H; Ding Y; Guo W; Qin P; Zhu W; Song C; Ma H; Zhang Q; Shen H
Cancer Med; 2022 Jun; 11(12):2482-2491. PubMed ID: 35384389
[TBL] [Abstract] [Full Text] [Related]
14. Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell lung cancer in Canada.
O'Sullivan DE; Cheung WY; Syed IA; Moldaver D; Shanahan MK; Bebb DG; Sit C; Brenner DR; Boyne DJ
Curr Oncol; 2021 Aug; 28(4):3091-3103. PubMed ID: 34436036
[TBL] [Abstract] [Full Text] [Related]
15. Serum Copper Level and the Copper-to-Zinc Ratio Could Be Useful in the Prediction of lung cancer and Its prognosis: A Case-Control Study in Northeast China.
Wang W; Wang X; Luo J; Chen X; Ma K; He H; Li W; Cui J
Nutr Cancer; 2021; 73(10):1908-1915. PubMed ID: 32896161
[TBL] [Abstract] [Full Text] [Related]
16. Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study.
Tamiya A; Koh Y; Isa SI; Kubo A; Ando M; Saka H; Yoshimoto N; Takeo S; Adachi H; Tagawa T; Kawashima O; Yamashita M; Kataoka K; Takenoyama M; Takeuchi Y; Watanabe K; Matsumura A; Kawaguchi T
Cancer Med; 2020 Apr; 9(7):2343-2351. PubMed ID: 32022477
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study.
Ravanelli M; Agazzi GM; Milanese G; Roca E; Silva M; Tiseo M; Rondi P; Baggi A; Ganeshan B; Muri M; Panni S; Botti C; Sverzellati N; Maroldi R; Berruti A; Farina D
Eur J Radiol; 2019 Sep; 118():251-256. PubMed ID: 31439251
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic and clinicopathologic significance of MicroRNA-125a-5p in cancers: A meta-analysis.
Ye H; Zhu W; Mei L; Lu Z
Medicine (Baltimore); 2019 Aug; 98(31):e16685. PubMed ID: 31374052
[TBL] [Abstract] [Full Text] [Related]
20. Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Liu L; Ruiz J; O'Neill SS; Grant SC; Petty WJ; Yang M; Chen K; Topaloglu U; Pasche B; Zhang W
Mol Cancer; 2018 Apr; 17(1):81. PubMed ID: 29650000
[TBL] [Abstract] [Full Text] [Related]
[Next]
